KTTA Earnings

Quarterly EPS
$-2.87
Q3 2024
$-2.53
Q4 2024
$-1.61
Q1 2025
$-0.66
Q2 2025
$-0.41
Q3 2025
$-0.79
Q4 2025
$-0.12
Q1 2026
$-0.16
Q2 2026
Latest RevenueN/A
Latest Net Income-5273852
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.160-5273852—+75.8%
Q1 2026-$0.120-2869482—+92.5%
Q4 2025-$0.790-10110868—+68.8%
Q3 2025-$0.410-3037420—+85.7%
Q2 2025-$0.660-3716157—+82.2%
Q1 2025-$1.610-3563238—+56.5%
Q4 2024-$2.530-3177661—+47.9%
Q3 2024-$2.870-2999834—+0.0%
Q2 2024-$3.710-3866249——
Q1 2024-$3.700-3860840——
Q4 2023-$4.860-5048159——
Q3 2023-$2.870-3612590——
Pasithea Therapeutics (KTTA) — Earnings